My Research – Session 5: Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation

Session 5 (Wednesday 15th September at 19:00 BST) in Collaboration with COSACPG

 

 

Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/

 

We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by: Julian Lindsay

Julian Lindsay (BPharm, MClinPharm, PhD candidate) is a Bone Marrow Transplant (BMT) Pharmacist at Royal North Shore Hospital in Sydney, Australia and a research fellow and PhD candidate at the National Center for Infection in Cancer (NCIC) at the Peter MacCallum Cancer Centre in Melbourne, Australia. His research interest is prevention of infections in patients with blood cancers and those undergoing bone marrow transplants including cytomegalovirus, Epstein-barr virus and invasive fungal infections. He will be conducting research full time in Seattle, USA, at The Fred Hutchinson Cancer Research Centre, in conjunction with the Peter MacCallum Cancer Centre in Melbourne, Australia. The research aims to address the critical knowledge gaps related to the optimization of antifungal prophylaxis, involving large scale clinical studies of patient outcomes when using new antifungal medications, as well as optimisation of antifungal dosing using pharmacogenomic testing to improve outcomes.

 

 

 

 

 

 

 

 

The session will be chaired by: Nick Duncan

Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

Nick is Secretary of the UK BMT Pharmacists Group – https://www.bopa.org.uk/membergroups/affiliated-groups/bmt-group/

 

 

 

 

 

Please Note:

-Webinars will start at 19:00 BST and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email [email protected])

-Webinars are FREE to access for BOPA Paid and BOPA FREE Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK

 

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

Latest News

By BOPA Executive Committee on 10th August 2026

Highlights of CAPhO Conference 2026 Webinar

Participants are invited to participate in the Highlights of CAPhO Conference 2026 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO). Taking place on Wednesday, August 19, 2026 at 08:00 PT,…

Read article
By BOPA Executive Committee on 10th August 2026

BOPA 2026 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2026 we received 9 nominations for 6…

Read article
By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article